Decreased octadecadienedioate levels can disrupt fatty acid metabolism, leading to lipid accumulation, inflammation, mitochondrial dysfunction, altered lipid signaling, and genetic/epigenetic changes, collectively impairing insulin sensitivity and increasing T2DM risk. Here, INS is linked to type 2 diabetes mellitus.